Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . UT The United Laboratories International Holdings Limited 聯邦 制藥 國際 控股 有限公司 ( Incorporated in the Cayman Islands with limited liability ) ( Stock Code : 3933 ) Interim Results Announcement For the six months ended 30 June 2021 FINANCIAL HIGHLIGHTS Six months ended 30 June 2021 RMB'000 2020 RMB'000 Increase Revenue 4,719,054 4,304,591 9.6 % EBITDA 1,056,821 755,797 39.8 % Profit before taxation 722,204 325,896 121.6 % Profit for the period attributable to the owners of the Company 623,076 202,836 207.2 % Earnings per share - Basic - Diluted RMB cents RMB cents 33.86 11.97 182.9 % 33.86 11.97 182.9 % -1-